Nicotine patch or gum vs lozenge

Many smokers crave a cigarette with coffee, so switching to tea while quitting could be a good option to cut the craving. Having a solid social support network can encourage individuals to meet their quitting goals and empower them to do so.

Humans are social beings who do well with support from others in difficult times, and smoking can be a challenging task to take on alone. While these treatments may not work for everyone, they can be an initial step to try and quit smoking, especially for individuals who are not yet severely dependent or use cigarettes to manage stress, anxiety and other issues. Nicotine is an addictive chemical, and many who find themselves wanting to quit cigarettes or other tobacco products may struggle to do so as a result.

Thus, NRTs are a good option for many individuals who would like to quit smoking, aside from pregnant women, teens, and those with serious health conditions who have not yet consulted a doctor about using NRTs. From the gum to lozenges to the patch to inhalers to sprays, the plethora of NRT options means individuals can find the best one for their budget, habits and lifestyles.

NRTs and other quitting strategies can also work best when combined with a quit plan. A variety of quitting hotlines, programs and apps can be used to supplement quitting efforts sought by those using NRTs.

Greater success in quitting is also expected if a combined, targeted approach is used to quit smoking cigarettes and using other tobacco products. Your email address will not be published.

Post Comment. Quit Smoking. Posted on 15 May No Comments. Contents hide. Leave a Reply Cancel reply Your email address will not be published. Save my name, email, and website in this browser for the next time I comment. Jennifer Ezell Jennifer is an experienced medical bloger who has worked with a variety of audiences of different age. She also has expierence in conducting a successful blog about medcine and other related issues.

Being professional in both bloging and medcine she is an important member of our team. This occurred because participants were asked only once at randomization to return unused NRT at the 8-week clinic visit and many participants forgot.

No other reminders were given and no aggressive NRT usage tracking was done, in keeping with the effectiveness study design. Thus, the results may be generalizable to the current population of smokers since smoking is becoming increasingly concentrated in low SES populations. This effectiveness study, conducted with a diverse urban population, identified a significant benefit of the nicotine lozenge in reducing post-cessation weight gain relative to nicotine gum.

It suggested a possible differential cessation benefit for male smokers, but this result was not consistently significant and would require replication.

Further research is needed to clarify the optimal agent for smoking cessation in general populations of smokers. We would like to thank Su Young Kim for his help with statistical analysis, Heather Vaughn for management of data entry and database, and the support staff at the Center for Tobacco Research and Intervention.

National Center for Biotechnology Information , U. Author manuscript; available in PMC Sep Quinn R. Pack , MD, 1, 2 Douglas E. Jorenby , PhD, 1, 2 Michael C. Piper , PhD, 2 and Timothy B. Baker , PhD 1, 2. Douglas E. Michael C. Megan E. Timothy B. Author information Copyright and License information Disclaimer. Corresponding Author. Phone: —— Fax: —— Copyright notice. The publisher's final edited version of this article is available free at WMJ.

See other articles in PMC that cite the published article. Abstract Context Both the nicotine gum and nicotine lozenge have been shown to increase smoking cessation rates but no published trials have directly compared the two.

Results At 8 weeks, the lozenge quit rate was Conclusions The gum and lozenge appear equally effective for smoking cessation; however, for patients concerned about preventing cessation related immediate weight gain, the lozenge may be the better agent. Gender Differences, Effectiveness.

Introduction Tobacco use is the number 1 cause of overall preventable mortality in the United States, accounting for approximately , deaths each year.

Screening and Eligibility Participants were recruited by press release, newspaper and radio ads, flyers, and word of mouth to join the study.

Statistical Methods All statistical tests were 2-sided with a Type I error rate of 0. Results Randomization A total of people were screened for participation. Table 1 Characteristics of Participants. Open in a separate window. Figure 1. Figure 2. CO confirmed Abstinence for Lozenge vs. Gum Collapsed across groups. Weight Outcomes Weight outcomes are shown in Table 3 by type of nicotine replacement therapy and smoking status.

Table 4 Reported Adverse Events. Discussion The study demonstrated a non-significant trend towards increased effectiveness of the lozenge for smoking cessation. Conclusions This effectiveness study, conducted with a diverse urban population, identified a significant benefit of the nicotine lozenge in reducing post-cessation weight gain relative to nicotine gum.

Acknowledgments We would like to thank Su Young Kim for his help with statistical analysis, Heather Vaughn for management of data entry and database, and the support staff at the Center for Tobacco Research and Intervention.

References 1. Preventing 3 million premature deaths and helping 5 million smokers quit: a national action plan for tobacco cessation. If your goal is to quit smoking, you can actually combine nicotine gum and patches to maximize your results. According to the National Institutes of Health, combining both a nicotine patch and gum will mean you are up to 4 times more likely to stay quit. Because it can take a few hours for the nicotine patch to start working, nicotine gum can come in clutch when you have intense cravings for a cigarette.

Because nicotine patches are classified as over-the-counter medication, you should be aware of common side effects to expect. Some complain about the habit of remembering to apply a new patch daily.

Others feel embarrassed or self-conscious about the appearance of a nicotine patch, or attempting to cut back on cigarettes. At the time of this writing, nicotine patch manufacturers do not produce a 42mg nicotine patch. However, clinical studies have been conducted to determine if 42mg of nicotine is more effective when used with smokeless tobacco users.

The study calls for using two 21mg nicotine patches per day, applied at the same time. If you smoke fewer than seven cigarettes a day, it is suggested that you begin with a 7 mg patch. On average, a one-pack-a-day smoker absorbs roughly 20 mg of nicotine. Some users have reported success with using more than one nicotine patch. Two 21mg patches can be combined and applied daily for 42mg of nicotine. While the fifty smokers represents a very small sample size, the study concluded success with helping smokers quit.

Am J Prev Med. Electronic cigarettes: review of use, content, safety, effects on smokers and potential for harm and benefit.

Cantrell FL. Adverse effects of e-cigarette exposures. Journal of community health. High-dose transdermal nicotine replacement for tobacco cessation. Am J Health Syst Pharm. Department of Veteran affairs. Electronic cigarettes as a smoking-cessation tool: results from an online survey. International Union against Tuberculosis and Lung diseases. Nicotine levels in electronic cigarettes. Palazzolo DL. Electronic cigarettes and vaping: a new challenge in clinical medicine and public health.

A literature review. Front Public Health. E-cigarettes: Safe to recommend to patients? Cleve Clin J Med. Lam C, West A. Are electronic nicotine delivery systems an effective smoking cessation tool? Can J Respir Ther. Electronic cigarettes for smoking cessation and reduction. Serum nicotine and cotinine levels during nicotine-patch therapy. Clin Pharmacol Ther.

High dose transdermal nicotine for fast metabolizers of nicotine: a proof of concept placebo-controlled trial. Are higher doses of nicotine replacement more effective for smoking cessation?

Effect of high-dose nicotine patch therapy on tobacco withdrawal symptoms among smokeless tobacco users. Rapid absorption of nicotine from new nicotine gum formulations. Pharmacol Biochem Behav. Comparative efficacy of rapid-release nicotine gum versus nicotine polacrilex gum in relieving smoking cue-provoked craving. Effectiveness of nicotine patch and nicotine gum as individual versus combined treatments for tobacco withdrawal symptoms. Combined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trial.

Prev Med. Combined use of nicotine patch and gum compared with gum alone in smoking cessation: a clinical trial in North Karelia.

Tob Control. Systematic review and meta-analysis of combination therapy for smoking cessation. J Am Pharm Assoc. Nicotine concentrations with concurrent use of cigarettes and nicotine replacement. Nicotine—mecamylamine treatment for smoking cessation: the role of precessation therapy. Exp Clin Psychopharmacol.

Precessation nicotine replacement therapy: pragmatic randomized trial. Investigations using immunization to attenuate the psychoactive effects of nicotine. Development of novel pharmacotherapeutics for tobacco dependence: progress and future directions. Smoking behaviour and compensation: a review of the literature. Nicotine vaccines for smoking cessation. Vaccines against drug abuse. Anti-addiction vaccines.

F Med Rep. Meyer B. How much nicotine kills a human? Tracing back the generally accepted lethal dose to dubious self experiments in the nineteenth century. Arch Toxicol. Nicotine: Pharmacology, Toxicity and Therapeutic use. J Smok Cessat. Are nicotine replacement strategies to facilitate smoking cessation safe? J Can Dent Assoc. Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: systematic review and meta-analysis.

Nicotine replacement therapy during pregnancy: recommended or not recommended? J Obstet Gynaecol Can. Smoking, Nicotine and Pregnancy Trial Team. The SNAP trial: a randomized placebo-controlled trial of nicotine replacement therapy in pregnancy--clinical effectiveness and safety until 2 years after delivery, with economic evaluation.

Health Technol Assess. Mendelsohn C. Optimising nicotine replacement therapy in clinical practice. Aust Fam Physician. Perceived safety and efficacy of nicotine replacement therapies among uS smokers and ex-smokers: relationship with use and compliance. Addict Behav.